JIMMY CHEN: Open Payments
NPI 1174615843 · FLUSHING, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$628 in 27 payments from 7 companies in 2025. Trend: 2023 $147 · 2024 $176 · 2025 $628
Food & beverage: $628
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $180 |
| E.R. Squibb & Sons, L.L.C. | 8 | $147 |
| Alkermes, Inc. | 4 | $96 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $86 |
| Janssen Pharmaceuticals, Inc | 2 | $61 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Lundbeck LLC | 1 | $18 |
Products named: ABILIFY MAINTENA, COBENFY, ARISTADA, CAPLYTA, SPRAVATO, ABILIFY ASIMTUFII, UZEDY, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
